Categories

• All
• Advisors - financial_ mortgage_ etc
• Cannabis/Hemp/Marijuana
• Conferences
• Crowdfunding
• Educational
• FinTech
• German/Mandarin/French
• Interviews/Management/CEO
• IR and other services for Pubcos
• New Listings
• News
• Presentations
• Private Companies (Accredited Investors)
• Private Placement Opportunities
• Regulatory - tax- accounting - listing
• Research Report Coverage
• Testimonial videos

Videos Tagged: apabetalone

Resverlogix has begun enrollment and dosing of patients in a Phase 2b clinical trial at a site at the University of Alberta Hospital in Edmonton, to evaluate the safety and efficacy of apabetalone as a potential oral treatment for COVID-19	Resverlogix in active discussions with the Kingdom of Morocco’s Ministry of Health for the launch of COVID-19 clinical studies involving apabetalone	Resverlogix reported that its Apabetalone drug met its primary endpoint in a pulmonary arterial hypertension or ‘PAH’ investigator led pilot study
Resverlogix receives approval from Health Canada for its COVID-19 Clinical Trial Application for apabetalone